Dokumen

Perbincangan Teknikal Ramalan Bermusim Opsyen

Pemfailan SEC dan dokumen lain Oric Pharmaceuticals, Inc.

Terokai dokumen syarikat terkini dan pemfailan SEC dari Oric Pharmaceuticals, Inc., termasuk Forms 10-K, 10-Q, 8-K dan pendedahan utama lain. Nilaikan prestasi kewangan dan kemas kini pengoperasian untuk melakukan keputusan lebih termaklum.

Rakan kongsi data

Huraian

Reported date

Borang

2025

Baird Global Healthcare Conference 2025

Sep 10, 2025

Transcript

Cantor Global Healthcare Conference 2025

Sep 05, 2025

Transcript

Citi's Biopharma Back to School Conference

Sep 03, 2025

Transcript

Company Presentation

Ogos 14, 2025

Slides

Q2 2025

Ogos 12, 2025

Quarterly report10-Q

Earnings release8-K

Study Update

Mei 28, 2025

Press release

Q1 2025

Mei 05, 2025

Quarterly report10-Q

Earnings release8-K

Oppenheimer 35th Annual Healthcare Life Sciences Conference 2025

Feb 11, 2025

Transcript

Guggenheim SMID Cap Biotech Conference

Feb 05, 2025

Transcript

2024

Q4 2024

Feb 18, 2025

Annual report10-K

Earnings release8-K

Q3 2024

Nov 12, 2024

Earnings release8-K

Quarterly report10-Q

Q2 2024

Ogos 12, 2024

Quarterly report10-Q

Earnings release8-K

Q1 2024

Mei 06, 2024

Quarterly report10-Q

Earnings release8-K

2023

Q4 2023

Mac 11, 2024

Earnings release8-K

Annual report10-K

Study Update

Dis 11, 2023

Press release

Q3 2023

Nov 06, 2023

Quarterly report10-Q

Earnings release8-K

Status Update

Okt 21, 2023

Press release

Q2 2023

Ogos 10, 2023

Quarterly report10-Q

Earnings release8-K

Q1 2023

Mei 08, 2023

Quarterly report10-Q

Earnings release8-K

2022

Q4 2022

Mac 16, 2023

Annual report10-K

2021

Q4 2021

Mac 21, 2022

Annual report10-K

2020

Q4 2020

Mac 23, 2021

Annual report10-K